OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of semaglutide on blood pressure in patients with type-2 diabetes: a systematic review and meta-analysis
Wei Wu, Huo-mu Tong, Yunsheng Li, et al.
Endocrine (2023) Vol. 83, Iss. 3, pp. 571-584
Open Access | Times Cited: 13

Showing 13 citing articles:

Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression
Frederick Berro Rivera, Grace Nooriza O. Lumbang, Danielle Rose Magno Gaid, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 6, pp. 2209-2228
Open Access | Times Cited: 16

Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease
Merita Rroji, Goce Spasovski
Biomedicines (2024) Vol. 12, Iss. 3, pp. 657-657
Open Access | Times Cited: 5

Contemporary Management of Obesity: A Comparison of Bariatric Metabolic Surgery and Novel Incretin Mimetic Drugs
Abhayjit Singh, Steven E. Nissen
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. 9, pp. 673-685
Closed Access | Times Cited: 2

The blood pressure-lowering property of subcutaneous semaglutide: a systematic review, meta-analysis, and meta-regression
Moein Ala, Mohammadreza Moheb Aleaba
Journal of Endocrinological Investigation (2024)
Closed Access | Times Cited: 1

How Would You Manage This Patient With Obesity? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Risa B. Burns, Melanie Jay, Anne N. Thorndike, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 10, pp. 1415-1424
Closed Access | Times Cited: 1

Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression
Frederick Berro Rivera, Grace Nooriza O. Lumbang, Danielle Rose Magno Gaid, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Is physical activity still the key to treating obesity? - semaglutide, a new position among therapies
Karolina Makowska, Marta Billewicz, Aleksandra Marczyk, et al.
Quality in Sport (2024) Vol. 20, pp. 54194-54194
Open Access

Alternative Perspectives on Obesity and Hypertension
Atara Schulhof, William H. Frishman
Cardiology in Review (2024)
Closed Access

Real-World Effectiveness of Oral Semaglutide in Indian Adult Diabetic Patients: Evaluation of EMR-based Data
Sandeep Gudibanda, Sharayu Govardhane, Supriya Kaloo, et al.
Journal of Diabetology (2024) Vol. 15, Iss. 4, pp. 421-428
Open Access

Page 1

Scroll to top